TARS

TARS Other Income/Expenses (Net)

$4.48MTTM · USD

Period ending:

TARS FY Other Income/Expenses (Net)USD
TARS FY Other Income/Expenses (Net)2018-12-31: $32.00K2019-12-31: -$371.00K2020-12-31: $173.00K2021-12-31: -$1.62M2022-12-31: $617.00K2023-12-31: $7.27M2024-12-31: $5.02M2025-12-31: $6.61M$7.27M-$1.62M
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TARS other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Tarsus Pharmaceuticals Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
6,610,000
5,015,000
7,265,000
617,000
-1,615,000
173,000
-371,000
32,000

Compare other income/expenses (net)

All TARS financial metrics · TARS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.